Done sou Salè H1B

Akèy › Kat vèt › Revance Therapeutics, Inc.

Revance Therapeutics, Inc.: sponso kat vèt (PERM)

Revance Therapeutics, Inc. te depoze 5 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 2. Mwayèn salè yo ofri $152,704; mwayèn tan soti nan depozisyon jiska sètifikasyon: 470 jou.

Aplikasyon PERM5
Sètifye2
Salè medyan ofri$152,704
Mwayèn jou pou sètifikasyon470
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)103
Nan biznis depi1999
Adrès anplwayèNashville, TN

Salè H-1B nan Revance Therapeutics, Inc. →

Tit travay

Tit travayAplikasyon PERMSalè medyan
Associate Scientist, Process Development1$117,875
Associate Director, IT, R&D1$187,533
Associate Product Manager1—
Software Engineer, Frontend1—
Data Test Engineer1—

Kote travay

Okipasyon

Dènye desizyon

Tit travaySalè bazKoteSoumètDesideEstatiJou
Associate Director, IT, R&D$187,533–$223,600Newark, CAMay 13, 2024Aug 26, 2025Sètifye470
Associate Scientist, Process Development$117,875–$162,000Newark, CAMay 13, 2024Aug 26, 2025Sètifye470
Software Engineer, Frontend$117,000–$130,000Pleasanton, CAJun 28, 2023Apr 2, 2024Retire—
Associate Product Manager$92,394–$119,000Nashville, TNJun 28, 2023Apr 2, 2024Retire—
Data Test Engineer$150,000–$160,000Pleasanton, CAJun 28, 2023Apr 2, 2024Retire—

Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).